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Abstract
Background: A distal radius fracture (DRF) is a common injury that can cause significant pain and lead to a prolonged
decrease in physical, emotional, and social functioning. In modern randomized clinical trials, assessing outcomes after a
DRF, health-related quality-of-life (HRQoL) is a “must-be” endpoint. Additionally, HRQoL assessments are essential in the
clinical decision-making process. The aim of this study to cross-culturally adapt the International Osteoporosis
Foundation Quality of Life Questionnaire (IOF QLQ) for patients with a DRF to Polish.
Methods: A standard forward-backward translation procedure and pilot-testing were used to prepare the Polish
version of the IOF QLQ for use in this case–control study. Patients were eligible if they were between 18–80 years
and were within 1–3 days after a non-comminuted DRF. The study group was gender and aged matched with healthy
controls. All DRF patients filled out the Polish version of the IOF QLQ, the SF-36 and a demographic questionnaire.
Assessment points were set as soon as possible after the fracture, 7 days, 6 weeks, 3, 6, 12, and 18 months after the
fracture. Standard validity and reliability analyses were performed.
Results: Ninety-seven patients (73 women – 75.3 %) with a mean age of 62.4 ± 7.1 years agreed to take part in the
study. The control group consisted of 81 patients (60 women – 74.1 %) with a mean age 63.9 ± 8.2 years. No significant
differences were found between the mean age of patients and controls (p = 0.19). Cronbach’s alpha coefficients
showed positive internal consistency (0.79–0.89). The interclass correlations for the IOF QLQ domains and the overall
score ranged from 0.85 to 0.92. Satisfactory convergent and discriminant validity of the IOF QLQ was seen.
Conclusions: The Polish version of the IOF QLQ for patients with a DRF is a reliable and valid tool for measuring HRQoL.
It can be fully recommended for use in clinical settings in the Polish population. When combined with the SF-36 the IOF
QLQ allows to obtain a comprehensive HRQoL assessment in patients with a DRF.
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Background
Distal radius fracture (DRF) is one of the most common
fractures, with an estimated annual incidence of 27 per
10,000 [1]. The incidence of DRF has a bimodal age distri-
bution, peaking in pediatric and elderly populations [2]. In
patients over the age of 65, DRF accounts for up to 18 % of
all of fractures, with an increasing incidence due to the
growing size of the elderly population [3, 4]. This peak in
DRF incidence in the elderly is likely attributable to the
increased risk of osteoporosis in postmenopausal women
[5]. In older individuals, DRF often occurs due to low-
energy force trauma, often due to a fall on a dorsally out-
stretched hand [4]. However in pediatric patients, where
DRF accounts for up to 25 % of all fractures, DRF is often
due to high-energy force trauma occurring through sport-
related injuries, playing, or accidents [2, 4].
A DRF often causes short-term functional limitations,
even after cast removal, such as a limited range of wrist
and forearm motion, and decreased grip strength [2].
However, a DRF does not only cause pain and a loss of
physical function, but also influences a patient’s emotional
and social function, thus leading to a decrease in overall
health-related quality-of-life (HRQoL) [6]. Furthermore,
up to 21.2 % patients with a DRF may never fully recover
from the injury, thus experiencing a permanent decrease
in their HRQoL [2].
Additionally, a DRF may have severe, long-term conse-
quences, such as the development of complex regional
pain syndrome (CRPS). The reported incidence of CRPS
in patients after a DRF ranges from 3.8 % to as high as
32.2 % [7, 8]. Furthermore, a decrease in a patient’s phys-
ical quality of life has been associated with an increase risk
of development of CRPS [7].
A DRF often occurs early in the course of osteoporosis,
while many patients are still employed and active [9]. As
such, the social effects of a DRF extend beyond just the
medical costs, resulting in loss of work hours, decreased
occupational performance, loss of independence, and po-
tential long-term disability [4, 10]. Thus, when considering
the multiple treatment options available for a patient pre-
senting with a DRF, it is important for clinicians to consider
HRQoL advantages and disadvantages of each therapy, and
tailor the treatment to each particular individual [11]. Add-
itionally, HRQoL questionnaires could be used to assess
patients in the first few months after fracture, when object-
ive physical testing is not possible [9].
In modern randomized clinical trials assessing outcomes
after a DRF, HRQoL is a “must-be” endpoint [12, 13].
Among the questionnaires used to assess recovery after a
DRF are instruments specific for wrist fracture (eg.
patient-rated wrist evaluation - PRWE), tools specific for
the hand or wrist (eg. Michigan Hand Outcomes Ques-
tionnaire - MHQ), tools covering the function of the
whole upper extremity (eg. disability of the arm, shoulder
and hand questionnaire – DASH and its abbreviated
version – quickDASH), as well as generic questionnaires
such as the short form 36 (SF-36) or the EQ-5D [9, 14,
15]. While tests like PRWE and DASH may be useful for
assessment of HRQoL for the purposes of clinical
research, their use in clinical practice is considered by
experts to be limited, lacking the valid information needed
for improving the clinical decision-making process [15].
In 2010, the Working Group for Quality of Life of the
IOF developed a questionnaire specific for HRQoL assess-
ment in patients with wrist fracture - the IOF quality of life
questionnaire for patients with wrist fracture (IOF QLQ)
[9]. This new tool was found to be a reliable and responsive
HRQoL questionnaire [9]. The latter, combined with the
fact that Polish clinical practice lacks validated tools for
HRQoL assessment in patients after a DRF, encouraged us
to undertake this study.
The aim of this study was cross-culturally adapt and
validate the IOF quality of life questionnaire for patients
with a DRF in a Polish population.
Materials and methods
Study design
The study was designed as prospective multi-center study
to assess the HRQoL in patients with a recent DRF as
compared to age- and gender- matched control subjects.
The patients were recruited between January 2013 and
November 2014, from three hospitals in Poland - the 5th
Military Hospital, Krakow, the Rydygier Specialistic Hos-
pital, Krakow, and the University Clinical Hospital, Lodz.
All patients with a DRF were followed for a period
18 months.
Subjects
Patients were recruited into two groups. The study group
comprised of patients with a radiographically confirmed
DRF (treated surgically or non-surgically) and were selected
by a qualified orthopedic surgeon (25+ years of experience).
Patients were eligible if they were above 18 and below
80 years old and were within 1–3 days after the fracture.
Exclusion criteria included lack of consent to participate in
the study, inability to understand or complete the question-
naires, reoperation or remanipulation of the fracture, com-
minuted or pathological fractures, patients after polytrauma
or patients with diseases with significant morbidity and
having a severe impact on HRQoL, including cancer, con-
gestive heart failure, and significant lung, renal, or liver
diseases. The control group consisted of patients selected
by an internal medicine physician (15+ years experience)
who were reporting to the outpatient office for a routine
annual checkup or for follow-up of mild disorders that did
not impact the individual’s HRQoL such as mild hyperten-
sion or the common cold. Patients in the control group
were chosen to gender and age match the subjects in the
Tomaszewski et al. Health and Quality of Life Outcomes  (2015) 13:158 Page 2 of 12
study group. Exclusion criteria included lack of consent to
participate in the study, inability to understand or complete
the questionnaires, severe arthritic changes, recent (up to
2 years) fractures and diseases having significant morbidity
and a severe impact on HRQoL including cancer, congest-
ive heart failure, and significant lung, renal, or liver diseases.
The primary purpose of the control group in the study was
to act as an estimate pre-fracture HRQoL level to compare
the baseline HRQoL levels of patients with a DRF, and for
assessment of the clinical validity of the IOF QLQ.
Sample size calculation
Study sample size was based on the proposal of Tabachnick
and Fidell [16], which states that in order to obtain reliable
estimates, the number of observations should be 5–10
times the number of variables in the model. Thus, the
required number of patients to conduct this study was
between 60 and 120.
Questionnaires
The SF-36 Health Survey is composed of 36 questions and
standardized response choices, organized into eight multi-
item scales: physical functioning (PF), role limitations due
to physical health problems (RP), bodily pain (BP), general
health perceptions (GH), vitality (VT), social functioning
(SF), role limitations due to emotional problems (RE), and
general mental health (MH). All raw scale scores are
linearly converted to a 0 to 100 scale, with higher scores
indicating higher levels of functioning or well-being. In
this study we have used the freely available, pretranslated
Polish version of the SF-36 [17].
The IOF QLQ for patients with wrist fracture (the trans-
lated Polish version can be seen in the Appendix) is com-
posed of 12 questions scored on a 1 to 5 Likert scale. The
questions form four domains – pain (question no. 1), upper
limb symptoms (questions no. 2–4), physical function
(questions no. 5–11), and general health (question no. 12).
The scores on individual questions were summed up to
form an overall score ranging from 12 to 60. This was later
recalculated by linear transformation of raw scores into a
score from 0 to 100, with 0 representing the best possible
HRQoL [9]. Permission to use the IOF QLQ was obtained
from the authors of the original study, and it should be
noted that the original study is published open-access [9].
The Gartland and Werley Score was first designed by
Gartland and Werley in 1951 [18]. The version used in
this study follows the modification of Chun and Palmer
[19]. This tool assesses wrist and hand function and is cal-
culated by the medical doctor after completing a detailed
patient history and physical examination. It assess wrist
pain, function, motion, grip strength, fracture union, post-
operative ulnar variance and whether any post-operative
complications have occurred using both a subjective
(patient reported) and objective (physical examination)
evaluation. The minimum score is 27.5, and the maximum
possible to obtain is 100 (representing best possible wrist
function). Depending on the number of points scored the
outcome is classified as excellent (no pain, disability, or
limitation of motion), good (occasional pain, mild limita-
tion of motion and function), or poor (severe pain, severe
limitation of motion and function).
Interview and examination procedure
The patients were recruited and informed about the details
of the study during their visits at the emergency depart-
ment or orthopedic outpatient clinics of the participating
centers or during their stay at the orthopedic clinic. The
interview and examination took place only after written,
informed consent was obtained. The whole procedure was
performed by qualified orthopedic surgeons.
For the study group, baseline patient characteristics
were gathered using a standard questionnaire which
enquired as to the gender and age of the patient, as well
as the date, side (left/right, dominant/non-dominant), type
of fracture and type of treatment (surgical or non-surgical
– closed reduction and casting). Next the examining
orthopedic surgeon, using the modified Gartland and
Werley score [19], assessed the physical function of the
wrist and hand of both upper limbs. After this, the patient
was asked to complete the following questionnaires – the
IOF QLQ and the SF-36.
Each patient was first examined as soon as possible after
the fracture by a qualified orthopedic physician (usually
on the same day the fracture occurred or within the next
24 h). Next, the patients were reexamined during each
control visit at 7 days, 6 weeks, 3, 6, 12, and 18 months
post fracture. Patients recruited to the control group were
interviewed only once (at baseline). Full medical history
was registered for each patient from their patient file.
During the interview process, assistance was offered to
patients, if necessary, in two ways: 1) if the patient’s domin-
ant extremity was fractured and the patient could not write,
the interviewer marked the answers on the questionnaire
for the patient and/or 2) if the patient did not have their
reading glasses available, the interviewer would read the
questions out loud to the patient. Interpreting questions or
providing suggestions from the side of the interviewer was
strictly forbidden.
A randomly chosen subset (based on a computer gener-
ated algorithm) of DRF patients (n = 30) completed one
additional interview to assess the stability of the IOF QLQ.
Patients in this subset completed one additional IOF QLQ
assessment 7 days after completing the IOF QLQ at
6 months. All patients agreed to fill in the questionnaire for
a second time.
Additionally, at the 12 month time point, patients in the
DRF study group were asked two additional questions as a
short qualitative survey: 1. Do you feel that in terms of
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your physical functioning you have returned to the pre-
fracture level? and 2. Do you feel that in terms of your
mental functioning you have returned to the pre-fracture
level?. The available answer choices were yes, no, or I do
not know.
Questionnaire translation
The translation was performed as per the European
Organization for Research and Treatment of Cancer
(EORTC) translation procedure [20] and per the guide-
lines developed by Beaton et al. [21] for cross-cultural
adaptation of self-reported measures. The process of the
questionnaire translation is outlined in Fig. 1.
In the next step, an expert panel was formed to confirm
the semantic, idiomatic, conceptual, and experimental
equivalence of the English and Polish questionnaire ver-
sions. The panel consisted of the project manager (ortho-
paedic surgeon), four translators who performed the
forward and backward translations, 5 health care profes-
sionals (2 orthopaedics surgeons, a rheumatologist, a nurse,
and a physical therapist), and an MSc in Polish studies.
The final Polish IOF QLQ version for pretesting was
prepared based on a consensus reached by the panelists.
It should be noted that the authors of this study have
previous experience with studies concerning questionnaire
validation in Polish populations [22, 23].
Pilot-testing
The preliminary Polish version of the IOF QLQ was pilot-
tested in a mixed group of 12 Polish patients with a DRF
(mixed time since fracture occurred, different treatment
methods). After reading and filling in the questionnaire,
the patients were asked whether they found any of the
questions difficult to answer, confusing, difficult to under-
stand, upsetting or offensive. If a patient reported any of
the above-mentioned problems, he or she was asked to
suggest an alternative way to phrase the question. After
completing the pilot testing phase, patients’ comments
were analyzed by the project manager.
Statistical analysis
Several pre-planned standard psychometric tests for qual-
ity of life studies, as outlined in the EORTC Module
Development Guidelines, were conducted in our analysis
[24]. Descriptive statistics (mean, standard deviation, per-
centage distribution) were used when appropriate to
analyze demographic data. The Shapiro-Wilk test or the
Kolmogorov-Smirnov test (as appropriate) were used to
assess the distribution of the results. Statistical analysis
was conducted using computer software Statistica 10.0 PL
by StatSoft Poland (licensed to the Jagiellonian University
Medical College). The significance level for all statistical
tests was set at p < 0.05.
Convergent and discriminant validity were used to assess
the construct validity of the domain structure of IOF QLQ.
Both convergent and discriminant validity were tested using
Spearman rank correlations, which were calculated between
similar domains of the two questionnaires. Convergent
validity was assessed by correlating each item with its own
domain of the IOF QLQ [25–27]. Evidence of item conver-
gent validity was defined as a correlation of 0.40 or greater
between an item and its own domain (corrected for over-
lap). Discriminant validity was assessed by correlating each
item with any other domain of the IOF QLQ [25, 26]. A
scaling success for an item was seen when the correlation
between an item and its own domain (corrected for over-
lap) was significantly higher (ie. two standard errors or
greater) than its correlation with other scales [26, 27]. Cal-
culating convergent and discriminant validity was only per-
formed for “upper limb symptoms” and “physical function”
Fig. 1 Flow chart of the process of cross-cultural adaptation of the
IOF quality of life questionnaire for patients with wrist fracture
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domains because of the original structure of the question-
naire. As the other domains have only one item each, it is
not possible to perform a correlation test.
Clinical validity was assessed using odds ratios. This
assesses how well a specific domain is able to discriminate
between groups of patients differing in clinical status [9]. In
our analysis, clinical validity was assessed as study group vs.
control group.
Reliability of the Polish version of the IOF QLQ was
assessed by measuring the internal consistency and test-
retest reliability. Cronbach’s alpha coefficient was calculated
to assess the internal consistency. Internal consistency esti-
mates of a magnitude of >0.70 were considered acceptable
for group comparisons [27]. Cronbach’s alpha was calcu-
lated for “upper limb symptoms” and “physical function”
domains as well as for the overall questionnaire score. Test-
retest reliability (stability) of the IOF QLQ was assessed
using interclass correlations (ICC) between baseline at
6 months and retest one week later. A correlation of >0.80
was considered ‘good’ [26, 27].
Assessment of the responsiveness of the scales to treat-
ment was performed by comparing IOF QLQ scores at dif-
ferent time points of the study (baseline vs. 7 days, 6 weeks,
3, 6, 12, 18 months assessment) using the Mann–Whitney
U test (due to the non-normal distribution of data). Similar
analysis was used to compare mean IOF QLQ scores
between subgroups of patients (male vs. female, dominant
hand vs. nondominant hand being fractured, and surgical
vs. nonsurgical treatment) in the study.
The acceptability of the IOF QLQ was assessed by the re-
sponse rate, percentage of missing data, assistance and time
needed to complete the questionnaire and details of items
considered upsetting, confusing or difficult in the question-
naire [22, 23, 25]. This assessment was carried out in the
same way as in the pilot-testing phase.
Ethics, consent and permissions
The research protocol was approved by the Jagiellonian
University Bioethics Committee (Registry No. KBET/176/
B/2011 and KBET/187/B/2014). The study has been per-
formed in accordance with the ethical standards laid down
in the 1964 Declaration of Helsinki and its later amend-
ments. Written, informed consent was obtained from each
and every patient, of both the control group and the study
group, before beginning the interview.
Fig. 2 Flow chart of patient recruitment, assessment, and attrition to follow up throughout the study. IOF-QLQ - International Osteoporosis Foundation
Quality of Life Questionnaire; G & W Score - Gartland and Werley Score
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Results
Since no significant differences were noted between the
original version of IOF QLQ and the two back translations,
the preliminary Polish version of the IOF QLQ was deemed
ready for pilot-testing. During pilot testing, patients found
all of the IOF QLQ questions acceptable and understand-
able. No language changes were needed to be made to the
original translation.
The flow of patients through the study is presented in
Fig. 2. During the recruitment period, 131 patients with a
DRF that qualified for the study were approached, of
which 74 % (n = 97 patients, 73 women - 75.3 %) agreed
to take part in the study. The mean age of the study group
was 62.4 ± 7.1 years. A total of 34 qualified DRF patients
(20 women - 58.8 %), with a mean age of 67.5 ± 7.5 years,
refused to take part in the study.
During the recruitment of controls, a total of 90 qualified
patients were approached to take part in the study, of which
90 % (n = 81 patients, 60 women – 74.1 %) agreed to
participate. The mean age of the control group was 63.9 ±
8.2 years. A total of 9 qualified patients (3 women- 33.3 %),
with a mean age of 59.3 ± 6.1 years, refused to participate in
the study as controls.
There were no significant differences between the mean
age of study group and the control group (p = 0.19).
Table 1 presents baseline characteristics of the study
group and attrition to follow-up. Additional demographic
characteristics of the study group and the control group
are presented in Table 2.
Overall, only 2.7 % of item responses were missing.
Forty-eight interviewees (49.5 %) required assistance
completing the questionnaires. Help was required mostly
in order to mark answers on the questionnaire, due to
the dominant extremity being fractured. The total time
for completion of the questionnaires (excluding physical
examination) was 17.2 ± 4.3 min without assistance, and
26.1 ± 5.5 min with assistance.
For the IOF QLQ “upper limb symptoms” domain, con-
vergent validity was 0.68–0.77, discriminant validity was
Table 1 Baseline characteristics of study participants
Feature Study group (n = 97)
Age (mean ± SD) [years] 62.4 ± 7.1
Gender Male (%) 24 (24.7 %)
Female (%) 73 (75.3 %)
Side of fracture Right (%) 39 (40.2 %)
Left (%) 58 (59.8 %)
Fracture of extremity Dominant (%) 40 (41.2 %)
Non-dominant (%) 57 (58.8 %)
Type of fracture Colles (%) 95 (97.9 %)
Smith (%) 2 (2.1 %)
Type of treatment Surgical (%) 33 (34 %)
Non-surgical (%) 64 (66 %)
SD standard deviation, n number
Table 2 Further demographic characteristics of the study and control groups
Variable Study group
(n = 97)
Control group
(n = 81)
p-value* (study vs.
control group)
Education
Elementary (%) 16 (16.5 %) 14 (17.3 %) 0.95
High School (%) 39 (40.2 %) 28 (34.6 %) 0.54
University (%) 42 (43.3 %) 39 (48.1 %) 0.63
Pre-fracture (study group) or
current (control group) working
status
Employed (%) 54 (55.7 %) 46 (56.7 %) 0.99
Unemployed (%) 7 (7.2 %) 3 (3.7 %) 0.49
Retired/Pensioner (%) 30 (30.9 %) 27 (33.4 %) 0.85
Student (%) 6 (6.2 %) 5 (6.2 %) 0.76
Living
Alone (%) 15 (15.5 %) 9 (11.2 %) 0.54
With partner or family (%) 70 (72.1 %) 62 (76.5 %) 0.62
With others (%) 12 (12.4 %) 10 (12.3 %) 0.84
Marital status
Single (%) 9 (9.3 %) 13 (16.1 %) 0.25
Married (%) 81 (83.5 %) 64 (79.0 %) 0.35
Divorced (%) 7 (7.2 %) 4 (4.9 %) 0.75
*calculated using the Mann–Whitney U test
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0.22–0.38, and Cronbach’s alpha was 0.86. For the “physical
function” domain convergent validity was 0.52–0.64, dis-
criminant validity was 0.09–0.27 and Cronbach’s alpha was
0.79. Cronbach’s alpha calculated for the overall question-
naire score was 0.89. Cronbach’s alpha values, in case a
specific item was deleted, are presented in Table 3.
In the assessment of test-retest stability, ICCs for the
IOF domains and the overall score ranged from 0.85 to
0.92, thus showing good repeatability of the scales.
Table 4 presents the discriminatory capacity of IOF
QLQ questions and domains. The odds ratio for patients
being categorized into the correct clinical status accord-
ing to the Gartland and Warley Score were high and
significant.
The IOF QLQ, the SF-36 and the Gartland and Warley
Score mean scores, and their change over time is shown in
Table 5. Changes over time in IOF QLQ domain scores in
subgroups according to patients’ gender, treatment type and
the dominant/non-dominant extremity being fractured are
presented in Table 6.
The majority of correlations between corresponding
domains of the IOF QLQ and the SF-36 questionnaires
were highly significant (p < 0.001), and all were strongly
negative (r = −0.52 to r = −0.76) due to the difference
in scoring of the two questionnaires. The correlations
are presented in Table 7. The strongest correlations
were noted between the “pain” and “bodily pain”
scales (r = −0.76; p < 0.001), both “physical function”
scales (r = −0.68; p < 0.001), and the “upper limb
symptoms” and the “role limitations due to physical
health problems” (r = −0.62; p < 0.001) scales.
A total of 81 DRF patients took part in the qualitative
survey at the 12 month time point. In response to the
question “Do you feel that in terms of your physical
functioning you have returned to the pre-fracture level?”,
88.9 % said yes, 8.6 % said no, and 2.5 % said I don’t
know. In response to the question “Do you feel that in
terms of your mental functioning you have returned to
the pre-fracture level?”, 92.6 % said yes, while 7.4 % said
no.
Discussion
Despite the fact that DRF is a common fracture, the current
literature lacks high-quality studies to define intervention
or evaluation of treatment outcomes in patients with DRF
[15]. Due to the high impact of a DRF on a patient’s phys-
ical, social, and emotional functioning, HRQoL is an essen-
tial measure for both evaluation of treatment outcomes in
RCTs and as a tool in the clinical-decision making process
[12, 13, 15]. While generic HRQoL measures such as the
SF-36 may help to assess the overall HRQoL of a patient,
and thus highlight important treatment-related issues, they
Table 3 Cronbach’s alpha values, in case a specific item was
deleted
Question
number
“Upper limb symptoms”
domain
“Physical function”
domain
Whole
questionnaire
Cronbach’s alpha value if all intended items present in domain/
questionnaire
- 0.86 0.79 0.89
Cronbach’s alpha value in case a specific item was deleted from the
domain/questionnaire
1 - - 0.80
2 0.80 - 0.83
3 0.77 - 0.79
4 0.81 - 0.84
5 - 0.76 0.87
6 - 0.67 0.79
7 - 0.72 0.84
8 - 0.71 0.83
9 - 0.75 0.87
10 - 0.72 0.84
11 - 0.74 0.85
12 - - 0.82
Table 4 The discriminatory capacity of IOF QLQ domains
3 months (n = 85) 6 months (n = 84) 12 months (n = 81) 18 months (n = 75)
IOF QLQ
domains
Unadjusted OR
(95 % CI)
Adjusted* OR
(95 % CI)
Unadjusted OR
(95 % CI)
Adjusted* OR
(95 % CI)
Unadjusted OR
(95 % CI)
Adjusted* OR
(95 % CI)
Unadjusted OR
(95 % CI)
Adjusted* OR
(95 % CI)
Pain 1.63 (1.34–1.96) 1.81 (1.38–1.93) 1.50 (1.31–1.82) 1.52 (1.31–1.83) 1.49 (1.29–1.82) 1.50 (1.30–1.78) 1.46 (1.30–1.87) 1.50 (1.22–1.70)
Upper limb
symptoms
1.37 (1.11–1.52) 1.40 (1.15–1.57) 1.35 (1.14–1.60) 1.35 (1.15–1.60) 1.33 (1.18–1.57) 1.35 (1.16–1.60) 1.34 (1.21–1.60) 1.38 (1.19–1.57)
Physical
function
1.39 (1.26–1.63) 1.39 (1.25–1.60) 1.34 (1.15–1.45) 1.39 (1.16–1.48) 1.33 (1.12–1.41) 1.40 (1.19–1.48) 1.35 (1.13–1.42) 1.49 (1.21–1.45)
General
health
1.18 (1.02–1.29) 1.20 (1.04–1.33) 1.16 (1.05–1.28) 1.18 (1.04–1.30) 1.21 (1.09–1.36) 1.21 (1.09–1.36) 1.21 (1.07–1.39) 1.25 (1.15–1.33)
Overall score 1.45 (1.30–1.71) 1.48 (1.31–1.73) 1.41 (1.28–1.67) 1.42 (1.26–1.67) 1.39 (1.22–1.65) 1.40 (1.22–1.68) 1.44 (1.24–1.61) 1.49 (1.25–1.69)
Odds ratios for being in the “poor” group vs. the “excellent” group according to the Modified Gartland & Werely score
OR odds ratio
*adjusted for age and gender. All OR given are with a p < 0.001
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Table 5 The IOF QLQ, the SF-36 and the Gartland and Werley score changes over time
Scale/Domain Baseline n = 97 7 days n = 97 6 weeks n = 92 3 months n = 85 6 months n = 84 12 months n = 81 18 months n = 75 Control group n = 81
IOF QLQ
Pain 69.7 (9.2) 58.1 (11.5) p < 0.0001 22.0 (7.4) p < 0.0001 14.6 (10.1) p < 0.0001 10.4 (6.7) p < 0.0001 7.5 (8.9) p < 0.0001 6.2 (9.1) p < 0.0001 0 p < 0.0001
Upper limb
symptoms
44.7 (14.0) 51.3 (13.6) p = 0.001 30.1 (10.7) p < 0.0001 21.4 (9.2) p < 0.0001 14.4 (11.5) p < 0.0001 3.7 (14.2) p < 0.0001 3.1 (11.5) p < 0.0001 0 p < 0.0001
Physical function 82.8 (9.0) 81.3 (11.6) p = 0.55 58.9 (15.2) p < 0.0001 33.1 (7.0) p < 0.0001 16.6 (13.4) p < 0.0001 9.7 (10.5) p < 0.0001 10.1 (11.1) p < 0.0001 12.1 (6.6) p < 0.0001
General health 78.1 (13.7) 83.1 (9.9) p = 0.004 60.8 (12.2) p < 0.0001 37.2 (18.6) p < 0.0001 20.7 (11.3) p < 0.0001 7.0 (4.9) p < 0.0001 7.3 (5.1) p < 0.0001 0 p < 0.0001
Overall score 67.4 (10.2) 65.9 (11.0) p = 0.33 48.3 (10.8) p < 0.0001 27.8 (9.7) p < 0.0001 16.1 (12.0) p < 0.0001 7.6 (10.4) p < 0.0001 6.8 (10.0) p < 0.0001 4.3 (2.7) p < 0.0001
SF-36
PF 59.7 (23.6) 57.1 (24.0) p = 0.45 66.4 (27.2) p = 0.07 73.6 (23.5) p = 0.0001 77.3 (20.1) p < 0.0001 84.1 (19.0) p < 0.0001 85.9 (16.8) p < 0.0001 87.0 (12.9) p < 0.0001
RP 15.1 (29.0) 27.4 (28.6) p = 0.003 38.0 (25.3) p < 0.0001 52.8 (21.2) p < 0.0001 59.3 (19.2) p < 0.0001 74.2 (21.4) p < 0.0001 81.5 (20.7) p < 0.0001 84.3 (24.1) p < 0.0001
BP 39.5 (27.1) 42.7 (24.1) p = 0.39 79.3 (19.3) p < 0.0001 79.8 (18.5) p < 0.0001 84.7 (17.2) p < 0.0001 87.5 (11.4) p < 0.0001 87.2 (12.1) p < 0.0001 88.7 (15.4) p < 0.0001
GH 63.5 (14.2) 65.2 (15.7) p = 0.43 74.1 (21.3) p = 0.0001 73.2 (20.2) p = 0.0002 75.7 (18.2) p < 0.0001 79.0 (15.6) p < 0.0001 78.3 (14.9) p < 0.0001 78.2 (14.4) p < 0.0001
VT 55.3 (16.9) 61.3 (26.2) p = 0.06 68.6 (20.4) p < 0.0001 71.0 (15.4) p < 0.0001 72.6 (13.1) p < 0.0001 73.3 (14.8) p < 0.0001 72.6 (12.8) p < 0.0001 73.7 (13.6) p < 0.0001
SF 51.7 (13.3) 51.4 (18.5) p = 0.90 69.2 (24.8) p < 0.0001 80.3 (22.5) p < 0.0001 88.1 (17.0) p < 0.0001 88.7 (20.5) p < 0.0001 88.9 (18.2) p < 0.0001 89.2 (18.3) p < 0.0001
RE 40.8 (17.0) 47.3 (20.6) p = 0.02 74.8 (17.6) p < 0.0001 83.4 (16.4) p < 0.0001 86.2 (19.8) p < 0.0001 90.4 (17.3) p < 0.0001 91.3 (21.4) p < 0.0001 90.0 (22.8) p < 0.0001
MH 67.4 (24.1) 70.3 (22.2) p = 0.39 78.8 (19.7) p = 0.0005 84.1 (16.4) p < 0.0001 82.0 (17.9) p < 0.0001 81.1 (22.6) p < 0.0001 82.3 (19.3) p < 0.0001 82.5 (19.9) p < 0.0001
Gartland & Werley score
Excellent (%) - - - 42.4 % 44.1 % 51.9 % 68.0 % -
Good (%) - - - 37.7 % 35.7 % 34.6 % 20.0 % -
Poor (%) - - - 19.9 % 20.2 % 13.5 % 12.0 % -
Data presented as mean values ± (SD). The p-values are comparing baseline and specific time point scores or baseline and the control group
SD standard deviation, n number, PF physical functioning, RP role limitations due to physical health problems, BP bodily pain, GH general health perceptions, VT vitality, SF social functioning, RE role limitations due to
emotional problems, MH general mental health
Tom
aszew
skiet
al.H
ealth
and
Q
uality
of
Life
O
utcom
es
 (2015) 13:158 
Page
8
of
12
have not been shown to be as responsive as more wrist spe-
cific assessments such as DASH and PRWE [14].
In this study, we have reported on the translation, pilot-
testing, and validation of the IOF QLQ for patients with
wrist fracture to confirm that this tool is an acceptable,
psychometrically and clinically robust measure to collect
HRQoL data in Polish patients with a DRF. To the best of
our knowledge, this was the first study to translate, pilot-
test and validate the IOF QLQ in Polish patients.
For a questionnaire to be acceptable for use in different
countries, it must be first translated and appropriately
validated in the target patient group. The results of our
study indicate that the Polish version of the IOF QLQ
demonstrates excellent agreement with the original lan-
guage version [9]. The pilot-testing phase showed that the
translated tool displays appropriate patient acceptability.
This was confirmed later in the study by the low percent-
age of missing item responses.
During the recruitment phase, we noticed that a high
percentage of patients (26.0 %) we planned to enroll in the
study group refused to participate. The mean age of
patients who refused to participate in the study was slightly
older (5.1 years) than those who agreed to participate, sug-
gesting that increased age was a factor in patient refusal.
Furthermore, we debated whether to attribute the high
rejection rate to the questionnaire format or to the fact that
these patients had just suffered a painful fracture. This was
later resolved when recruiting the control group, where
patients were much more willing to take part in the study,
thus showing that the questionnaire itself is an acceptable
measure. The mean age of those refusing to participate as a
control in the study was slightly younger (4.6 years) than
those who agreed to participate as controls. We suspect
that this was due to younger patients being more active and
less willing to spend time participating in a study.
Data analysis revealed that both tested IOF QLQ
domains as well as its overall score demonstrated appro-
priate Cronbach’s alpha values. This confirms the results
from the international field study [9], proving IOF QLQs’
excellent internal consistency. Test-retest values in our
Table 6 The IOF QLQ score changes over time between patient subgroups
Assessment time-point Mean (SD) p-value*
Surgical Non-surgical
0 68 (21.7) 67.1 (17.6) 0.83
1 week 60.9 (16.9) 68.5 (15.1) 0.027
6 weeks 36.7 (13.1) 54.3 (10.4) <0.0001
3 months 21.4 (9.4) 31.1 (10.8) <0.0001
6 months 10.7 (11.5) 18.9 (7.3) <0.0001
12 months 5.9 (5.8) 8.5 (7) 0.07
18 months 5.3 (6.1) 7.5 (8.2) 0.18
Males Females
0 59.2 (14.2) 70.1 (18.2) 0.009
1 week 59.5 (15.6) 68 (22) 0.08
6 weeks 50.1 (15.1) 47.7 (19.4) 0.58
3 months 21.7 (11.2) 29.8 (11.5) 0.003
6 months 11.5 (6.5) 17.6 (8.7) 0.002
12 months 5.8 (4.8) 8.2 (5.9) 0.07
18 months 5.3 (4.1) 7.1 (5.8) 0.16
Dominant Non-dominant
0 72.1 (24.9) 64.1 (18.4) 0.07
1 week 70.9 (21.6) 62.4 (19.2) 0.04
6 weeks 60.6 (15.1) 39.7 (14) <0.0001
3 months 39.9 (9.8) 19.3 (11.4) <0.0001
6 months 22.5 (11.3) 11.6 (8.7) <0.0001
12 months 10 (7.4) 5.9 (5.2) 0.0018
18 months 8.2 (6.6) 4.7 (4.3) 0.0021
The p-values are comparing the mean scores within each of the subgroups
SD standard deviation
*calculated using the Mann–Whitney U test
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study were found to be superior to those of the original
study [9]. This might originate from the fact that Lips et
al. [9] decided to assess IOF QLQ for stability at 3 months
post fracture, with a 2 week period separating the test-
retest interviews. At this time-point in the healing of a
fracture, we suspected that 2 weeks may be enough time
to change a patients’ HRQoL. This is why we choose to
test-retest the IOF QLQ after 1 week at the 6 months post
fracture time-point.
The results of known-group comparison demonstrated
that the IOF QLQ is able to discriminate between patients
differing in clinical status (study vs. control group), regard-
less of the time-point at which the assessment was carried
out. Our findings confirm the discriminatory results
reported by Lips et al. [9].
All of the four IOF QLQ domains, as well as its overall
score, showed adequate responsiveness to change at
almost every time-point, apart from the second assess-
ment 7 days after the fracture. This early post-trauma
period is characterized by a varying clinical course among
patients, some presenting with more severe fractures than
others, which may lead to significant short-term changes
in HRQoL perception among different patients. Apart
from demonstrating that the IOF QLQ responsiveness to
change over a 12 month period is adequate in patients after
a DRF, this study also depicted the history of HRQoL
change in patients recovering after a DRF. The most signifi-
cant HRQoL changes could be seen in the first 3 months
after the fracture, which stands in agreement with other
similar studies [9, 14, 28]. Between 12 and 18 months after
a DRF, a patients’ HRQoL returned almost to the level
displayed by the gender and age matched control group.
The SF-36 scores proved a similar thesis, that HRQoL
after a DRF returns to pre-fracture levels at 12 months
after the injury. However the SF-36, supplemented by the
qualitative assessment of patients mental function at
12 month time point, added information that the return
to health was not only limited to physical function, but
also included improvement of the mental aspect of
HRQoL.
As could have been expected, patients with a fracture of
the dominant extremity had a lower HRQoL, most prob-
ably because they were less able to care for themselves. This
difference persisted throughout the study, including up to
the last time point assessment of 18 months. This finding
was also reported by Lips et al. [9], and confirms the face
validity of IOF QLQ.
Patients receiving surgical treatment had a faster return
to their pre-injury HRQoL. The HRQoL difference be-
tween surgically and non-surgically treated patients was
most notable in the first 3–6 months after the DRF. How-
ever it is important to note that the HRQoL outcome after
18 months was similar in both groups. There were no
important differences in overall IOF QLQ scores between
genders, with women displaying only slightly lower
HRQoL at 1 year post DRF.
The strong correlations in our study between similar
IOF QLQ domains and the SF-36 scales is an important
Table 7 Correlation between domains of the IOF QLQ and the SF-36 questionnaires
Scale/
Domain
IOF QLQ IOF QLQ IOF QLQ IOF QLQ IOF QLQ
Pain Upper limb symptoms Physical function General health Overall score
SF-36 PF R = −0.50 R = −0.53 R = −0.68 R = −0.59 R = −0.54
P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001
SF-36 RP R = −0.55 R = −0.62 R = −0.59 R = −0.57 R = −0.48
P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001
SF-36 BP R = −0.76 R = −0.49 R = −0.61 R = −0.53 R = −0.52
P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001
SF-36 GH R = −0.55 R = −0.42 R = −0.44 R = −0.61 R = −0.57
P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001
SF-36 VT R = −0.53 R = −0.39 R = −0.58 R = −0.63 R = −0.59
P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001
SF-36 SF R = −0.44 R = −0.37 R = −0.40 R = −0.42 R = −0.39
P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001
SF-36 RE R = −0.41 R = −0.29 R = −0.37 R = −0.36 R = −0.33
P < 0.001 P < 0.05 P < 0.001 P < 0.001 P < 0.001
SF-36 MH R = −0.39 R = −0.23 R = −0.30 R = −0.34 R = −0.37
P < 0.001 P > 0.05 P < 0.05 P < 0.05 P < 0.001
The p-values indicate significance of correlation between two domains
PF physical functioning, RP role limitations due to physical health problems, BP bodily pain, GH general health perceptions, VT vitality, SF social functioning, RE role
limitations due to emotional problems, MH general mental health
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finding. Generic measures, like the SF-36, have some
degree of specificity, however, it should be recognized that
the term generic is relative and does not indicate universal
applicability [29]. Due to the similarities between the two
questionnaires, it would be possible to use the IOF QLQ
and the SF-36 in conjunction to comprehensively assess
HRQoL in patients with a DRF. To shorten the time
needed for questionnaire completion, we suggest exclud-
ing the SF-36 questions pertaining to physical function, as
this part would be covered by the IOF QLQ.
This study has a number of strengths. First, there was a
large study group, with a well matched gender and age con-
trol group. Second, the follow-up attrition was minimal.
Third, the assessment points were strictly adhered to. If a
patient did not show up for a follow-up assessment, one of
the study authors would call and invite the patient for a
separately scheduled control visit. However, this study is
not without limitations. First, there was a high rejection rate
among patients we attempted to the recruit to the patient
study group. Second, the inclusion/exclusion criteria may
have biased the HRQoL score. Patients with comminuted
fracture were excluded from the study, and their HRQoL
would most likely be lower than the scores obtained in this
study. However, this would most probably not have an
impact on the overall psychometric properties of the IOF
QLQ, but would likely influence HRQoL score changes
over the follow-up period. We also did not compare the
IOF QLQ to other “wrist-specific” instruments such as the
DASH or the PRWE. However this was done intentionally,
as this study aimed only at translating and validating the
IOF QLQ, and comparing it to a generic HRQoL measure
– the SF-36. We plan to compare the IOF QLQ to other
“wrist-specific” tools in future studies.
Conclusions
The Polish version of the IOF QLQ for patients with wrist
fractures is a reliable and valid tool for measuring HRQoL
in patients with a DRF. It can be fully recommended for
use in clinical settings in the Polish population. When com-
bined with the SF-36, the IOF QLQ allows to obtain a com-
prehensive HRQoL assessment in patients with a DRF.
Appendix
The final Polish translation of the IOF quality of life
questionnaire for patients with wrist fracture
Kwestionariusz IOF do oceny jakości życia u pacjen-
tów ze złamaniem okolicy nadgarstka
Wszystkie pytania odnoszą się do ostatniego tygodnia,
z wyjątkiem pytania numer 12.
Proszę udzielić odpowiedzi na wszystkie pytania, nie-
zależnie od strony złamania i kończyny dominującej.
1. Czy nadal odczuwa Pan/Pani ból w miejscu
złamania przedramienia lub ręki?
Wogóle; Trochę; Umiarkowanie; Dosyć mocno; Bardzo
mocno.
2. Czy nadal odczuwa Pan/Pani drętwienie lub
uczucie mrowienia w złamanym przedramieniu lub
ręce?
Wogóle; Trochę; Umiarkowanie; Dosyć mocno; Bardzo
mocno.
3. Czy odczuwa Pan/Pani sztywność w złamanym
przedramieniu lub ręce?
Wogóle; Trochę; Umiarkowanie; Dosyć mocno; Bardzo
mocno.
4. Czy niepokoi się Pan/Pani deformacją złamanego
przedramienia?
Wogóle; Trochę; Umiarkowanie; Dosyć mocno; Bardzo
mocno.
5. Czy jest Pan/Pani w stanie umyć lub wysuszyć
suszarką swoje włosy?
Bez trudności; Z niewielką trudnością; Z umiarkowaną
trudnością; Z dużą trudnością; Nie jestem w stanie
wykonać tych czynności.
6. Czy jest Pan/Pani w stanie przekręcić klucz w
zamku lub odkręcić pokrywkę słoika?
Bez trudności; Z niewielką trudnością; Z umiarkowaną
trudnością; Z dużą trudnością; Nie jestem w stanie
wykonać tych czynności.
7. Czy ma Pan/Pani problemy z wykonywaniem pracy
zawodowej lub prac domowych?
Bez trudności; Z niewielką trudnością; Z umiarkowaną
trudnością; Wymagam pewnej pomocy; Nie jestem w
stanie wykonać tych czynności.
8. Czy ma Pan/Pani problemy z pisaniem odręcznie lub
pisaniem na maszynie/klawiaturze komputerowej?
Bez trudności; Z niewielką trudnością; Z umiarkowaną
trudnością; Z dużą trudnością; Nie jestem w stanie
wykonać tych czynności.
9. Czy jest Pan/Pani w stanie korzystać z własnego
środka transportu tj. prowadzić samochód lub
jeździć na rowerze?
Bez trudności; Z niewielką trudnością; Z umiarkowaną
trudnością; Z dużą trudnością; Nie jestem w stanie
wykonać tych czynności.
10. W jakim zakresie Pana/Pani złamane przedramię
przeszkadzało w zajęciach w trakcie ostatniego
tygodnia?
Wogóle; Trochę; Umiarkowanie; Dosyć mocno; Bardzo
mocno.
11. Czy potrzebuje Pan/Pani pomocy ze strony
przyjaciół lub krewnych z powodu złamania
przedramienia?
Nie potrzebuję; 1 dzień w tygodniu lub mniej; 2–3 dni
w tygodniu; 4–6 dni w tygodniu; Codziennie.
12. Czy w Pana/Pani ocenie, Pana/Pani jakość życia, w
przeciągu ostatnich 3 miesięcy pogorszyła się ze
względu na złamanie przedramienia?
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Wogóle; Trochę; Umiarkowanie; Dosyć mocno; Bardzo
mocno.
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